Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Knoxville, TN
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Austin, TX
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated:  12/1/2016
MedaPhase, Inc.
mi
from
Newnan, GA
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated: 12/1/2016
MedaPhase, Inc.
mi
from
Newnan, GA
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated:  12/1/2016
NW Dermatology & Research Center, LLC
mi
from
Portland, OR
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated: 12/1/2016
NW Dermatology & Research Center, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated:  12/1/2016
Tennessee Clinical Research Center
mi
from
Nashville, TN
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated: 12/1/2016
Tennessee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated:  12/1/2016
Axis Clinical Tirals
mi
from
Los Angeles, CA
Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia
Status: Enrolling
Updated: 12/1/2016
Axis Clinical Tirals
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris
A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  12/5/2016
Sadick Research Group
mi
from
New York, NY
A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris
A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 12/5/2016
Sadick Research Group
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of 1.5 mg/kg/Day of Sarecycline vs Placebo in the Treatment of Acne Vulgaris
A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/5/2016
Sadick Research Group
mi
from
New York, NY
Study to Evaluate the Efficacy and Safety of 1.5 mg/kg/Day of Sarecycline vs Placebo in the Treatment of Acne Vulgaris
A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 1.5 mg/kg Per Day of Sarecycline Compared to Placebo in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/5/2016
Sadick Research Group
mi
from
New York, NY
Click here to add this to my saved trials
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
Endothelial Mircroparticles as a Biomarker of Pulmonary Hypertension in Systemic Sclerosis
Status: Enrolling
Updated:  12/15/2016
Lsu Health Sciences Center
mi
from
New Orleans, LA
Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
Endothelial Mircroparticles as a Biomarker of Pulmonary Hypertension in Systemic Sclerosis
Status: Enrolling
Updated: 12/15/2016
Lsu Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Encino, CA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Encino, CA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Fullerton, CA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Fullerton, CA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
La Mesa, CA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Los Angeles, CA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Sherman Oaks, CA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Temecula, CA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Temecula, CA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Boca Raton, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Brandon, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Hialeah, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Miami, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Miramar, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Miramar, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
S Tampa, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
S Tampa, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Tampa, FL
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Savannah, GA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Savannah, GA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
New Orleans, LA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Norfolk, NE
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Norfolk, NE
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Omaha, NE
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Omaha, NE
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Las Vegas, NV
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Endwell, NY
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Endwell, NY
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
New York, NY
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
High Point, NC
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
High Point, NC
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Wilmington, NC
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Wilmington, NC
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Cincinnati, OH
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Jenkintown, PA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Upper St Clair, PA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Upper St Clair, PA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Warminster, PA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Warminster, PA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Nashville, TN
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Nashville, TN
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Austin, TX
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
El Paso, TX
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
El Paso, TX
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Mesquite, TX
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Mesquite, TX
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Norfolk, VA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Norfolk, VA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Richland, WA
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Richland, WA
Click here to add this to my saved trials
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated:  12/19/2016
Catawba Clinical Research
mi
from
Belize City,
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Status: Enrolling
Updated: 12/19/2016
Catawba Clinical Research
mi
from
Belize City,
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
Santa Monica, CA
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
Coral Gables, FL
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
Lake Mary, FL
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
Lake Mary, FL
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
Newnan, GA
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
Louisville, KY
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
Las Vegas, NV
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
mi
from
Montclair, NJ
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
mi
from
Montclair, NJ
Click here to add this to my saved trials
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated:  1/3/2017
Clinical Research Facility
mi
from
New York, NY
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status: Enrolling
Updated: 1/3/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials